The March 2023 quarter revenue stood at Rs. 808.03 millions, up 9.79% as compared to Rs. 735.99 millions during the corresponding quarter last year.Net profit for the quarter ended March 2023 increases to Rs. 122.50  millions from Rs. 118.76 millions.Operating Profit saw a handsome growth to 242.24 millions from 234.91 millions in the quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 808.03 735.99 9.79 3151.16 2759.80 14.18 3151.16 2759.80 14.18
Other Income 6.65 4.19 58.71 34.68 14.54 138.51 34.68 14.54 138.51
PBIDT 242.24 234.91 3.12 970.15 812.26 19.44 970.15 812.26 19.44
Interest 2.48 5.74 -56.79 26.44 14.96 76.74 26.44 14.96 76.74
PBDT 239.76 229.17 4.62 943.71 785.06 20.21 943.71 785.06 20.21
Depreciation 79.98 66.44 20.38 305.40 231.58 31.88 305.40 231.58 31.88
PBT 159.78 162.73 -1.81 638.31 553.48 15.33 638.31 553.48 15.33
TAX 37.28 43.97 -15.21 165.32 142.90 15.69 165.32 142.90 15.69
Deferred Tax -0.18 5.40 -103.33 -22.37 -10.33 116.55 -22.37 -10.33 116.55
PAT 122.50 118.76 3.15 472.99 410.58 15.20 472.99 410.58 15.20
Equity 44.26 44.22 0.09 44.26 44.22 0.09 44.26 44.22 0.09
PBIDTM(%) 29.98 31.92 -6.07 30.79 29.43 4.60 30.79 29.43 4.60

Vimta Labs Share Price

507.20 -16.60 (-3.17%)
06-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1529.55
Dr. Reddys Lab 6315.00
Cipla 1423.40
Zydus Lifesciences 1021.00
Lupin 1679.75
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.